| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |